ZLD 24.8% 75.5¢ zelira therapeutics limited

Non-commercial prices for "research" being paid to closely related parties, page-20

  1. 1,869 Posts.
    lightbulb Created with Sketch. 1472
    With all this talk regarding Zeldas strategy and "novel" or not nature of the IP and patents, more or less useless to debate this.

    Market will decide as always, and when the money returns to the specs and hopefully in the sector too the writing will be on the wall in regards to the future of ZLD.

    IMO in the next spec run only a few of the MM stocks will be able to breakthrough the supply of the baggies of the previous run.

    Most are trash and will be outed as such.
    Leave for the market to decide. No need to stress over this now, just be aware when the next spec run hits how ZLD reacts.
 
watchlist Created with Sketch. Add ZLD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.